The ‘EFIB 2021 Vienna Statement’ marked the launch of an annual call to action from EuropaBio members, with policy asks and actions critical in the short term for Europe’s delivery of a bioeconomy.
Developed through 2021 and published at EFIB in Vienna, the statement includes:
• Next generation Europe: An urgent call to action
• Industrial biotechnology: Proving its value to society, environment and economy
• The clock is ticking for European climate and competitive ambitions
• Time is now – EFIB Vienna Statement requests for modernisation of regulation and policy, Education and awareness and financing innovation
Moderator:
• Dr Claire Skentelbery, Director General, EuropaBio
Speakers:
• Stefan Buchholz, Senior Vice President R&D Nutrition & Care, Evonik
• Elke Duwenig, Senior Biotechnology Expert Regulatory / Public & Government Affairs, Nutrition & Health, BASF
• Jim Philp, Science and Technology Analyst, OECD
• Video message by Simone Schmiedtbauer, Member of the European Parliament, Group of the European People’s Party, Austria
• Video message by Virginijus Sinkevičius, European Commissioner for Environment, Oceans and Fisheries
We invite you now to join us for the wider launch of the EFIB Vienna Statement – to set the challenge for Europe and discuss what this means for policy, regulation, investment and innovation.
Join us on 30 November at 14:00 CET and be part of the conversation in the 12 months until the next EFIB conference in Vilnius, Lithuania, October 2022.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.